Recent Patents on Anti-Cancer Drug Discovery

Khurshid Zaman  
Bentham Science Publishers
USA

Back

Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis

Volume:1   Issue:2
Pp: 153-161
Mark N. Kirstein, Megan M. Moore and Arkadiusz Z. Dudek
DOI: 10.2174/157489206777442269

Order Reprints Order Eprints

Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues

Volume:1   Issue:2
Pp: 163-170
Lars P. Jordheim, Carlos M. Galmarini and Charles Dumontet
DOI: 10.2174/157489206777442205

Order Reprints Order Eprints

Tetraplex Binding Molecules as Anti-Cancer Agents

Volume:1   Issue:2
Pp: 185-200
Kevin M. Doherty, Sudha Sharma, Rigu Gupta and Robert M. Brosh Jr.
DOI: 10.2174/157489206777442232

Order Reprints Order Eprints

EGF-R Small Inhibitors and Anti-EGF-R Antibodies: Advantages and Limits of a New Avenue in Anticancer Therapy

Volume:1   Issue:2
Pp: 209-222
Michele Caraglia, Monica Marra, Giusy Meo, Raffaele Addeo, Pierosandro Tagliaferri and Alfredo Budillon
DOI: 10.2174/157489206777442250

Order Reprints Order Eprints

The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors

Volume:1   Issue:2
Pp: 237-254
Gabriela Melen-Mucha, Hanna Lawnicka, Dorota Kierszniewska-Stepien, Jan Komorowski and Henryk Stepien
DOI: 10.2174/157489206777442197

Order Reprints Order Eprints

Patent Annotations

Volume:1   Issue:2
Pp: 297-302
Bentham Science Publishers
DOI: 10.2174/157489206777442223

Order Reprints Order Eprints

Patent Selections promotion: free to download

Volume:1   Issue:2
Pp: 303-304
Bentham Science Publishers
DOI: 10.2174/157489206777442278

Order Reprints Order Eprints